Overview

Assessment of Serum Catestatin Level in Acne Vulgaris Patients

Status:
RECRUITING
Trial end date:
2026-01-10
Target enrollment:
Participant gender:
Summary
Acne vulgaris is a persistent inflammatory condition of the pilosebaceous unit, affecting 85% of people between the ages of 12 and 24, it is regarded as one of the most common diseases in teenagers and young adults. Catestatin, a peptide derived from chromogranin A (CgA), was first discovered in 1997 as an acute nicotinic-cholinergic antagonist. Later, it was determined that CST is a pleiotropic hormone.
Phase:
NA
Details
Lead Sponsor:
Aswan University
Treatments:
chromogranin A (344-364)
Isotretinoin